Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes

Neurobiology of Aging

Volumn 35, Issue 11, 2014, Pages 2657.e13-2657.e19

  Thelen, Mathias ^a   Razquin, Cristina ^b,c   Hernández, Isabel ^d   Gorostidi, Ana ^c,e   Sánchez Valle, Raquel ^f   Ortega Cubero, Sara ^b,c   Wolfsgruber, Steffen ^a,g   Drichel, Dmitriy ^g   Fliessbach, Klaus ^a,g   Duenkel, Tanja ^h   Damian, Marinella ^h   Heilmann, Stefanie ^a   Slotosch, Anja ^a   Lennarz, Martina ^a   Seijo Martínez, Manuel ⁱ   Rene, Ramón ^j   Kornhuber, Johannes ^k   Peters, Oliver ^l   Luckhaus, Christian ^m   Jahn, Holger ⁿ   Hüll, Michael ^o   Rüther, Eckart ^p   Wiltfang, Jens ^p   Lorenzo, Elena ^b,c   Gascon, Jordi ^j   Lleó, Alberto ^c,q   Lladó, Albert ^f   Campdelacreu, Jaume ^j   Moreno, Fermin ^c,e,r   Ahmadzadehfar, Hojjat ^a   Fortea, Juan ^c,q   Indakoetxea, Begoña ^c,e,r   Heneka, Michael T ^a,g   Wetter, Axel ^s   Pastor, Maria A ^b,t   Riverol, Mario ^t   Becker, Tim ^a,g   Frölich, Lutz ^h   Tárraga, Lluís ^d   Boada, Mercè ^d   Wagner, Michael ^a,g   Jessen, Frank ^a,g   Maier, Wolfgang ^a,g   Clarimón, Jordi ^c,q   López de Munain, Adolfo ^c,e,r,u   Ruiz, Agustín ^d   Pastor, Pau ^b,c,t   Ramirez, Alfredo ^a   more..

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF NAVARRA   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^d Institut Catala de Neurociencies Aplicades   (Spain)

^e BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^f HOSPITAL CLÍNIC   (Spain)

^g GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ Hospital do Salnes   (Spain)

^j HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^k UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^l CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^m Department of Orthopedic Surgery   (Germany)

ⁿ UNIVERSITY OF HAMBURG   (Germany)

^o UNIVERSITY OF FREIBURG   (Germany)

^p UNIVERSITY OF GÖTTINGEN   (Germany)

^q UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^r HOSPITAL DONOSTIA   (Spain)

^s UNIVERSITY OF DUISBURG ESSEN   (Germany)

^t UNIVERSITY CLINIC OF NAVARRA   (Spain)

^u UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

more..

Author keywords

Alzheimer's disease; Case control studies; Frontotemporal dementia; Genetic association studies

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GERMAN (CITIZEN); HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MOLECULAR PATHOLOGY; PROTEIN PHOSPHORYLATION; SEQUENCE ANALYSIS; SPANIARD; TREM2 GENE; VERY ELDERLY;

EID: 84922941757     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.06.018     Document Type: Article

References (32)

1. Allcock R.J., Barrow A.D., Forbes S., Beck S., Trowsdale J. The human TREM gene cluster at 6p21.1 encodes both activating and inhibitory single IgV domain receptors and includes NKp44. Eur. J. Immunol. 2003, 33:567-577.
2. Balasa M., Sánchez-Valle R., Antonell A., Bosch B., Olives J., Rami L., Castellví M., Molinuevo J.L., Lladó A. Usefulness of biomarkers in the diagnosis and prognosis of early-onset cognitive impairment. J. Alzheimers Dis 2014, 40:919-927.
3. Becker J.T., Huff F.J., Nebes R.D., Holland A., Boller F. Neuropsychological function in Alzheimer's disease. Pattern of impairment and rates of progression. Arch. Neurol. 1988, 45:263-268.
4. Benitez B.A., Cooper B., Pastor P., Jin S.C., Lorenzo E., Cervantes S., Cruchaga C. TREM2 is associated with the risk of Alzheimer's disease in Spanish population. Neurobiol. Aging 2013, 34:1711.e15-1711.e17.
5. Borroni B., Ferrari F., Galimberti D., Nacmias B., Barone C., Bagnoli S., Fenoglio C., Piaceri I., Archetti S., Bonvicini C., Gennarelli M., Turla M., Scarpini E., Sorbi S., Padovani A. Heterozygous TREM2 mutations in frontotemporal dementia. Neurobiol. Aging 2014, 35:934.e7-934.e10.
6. Boxer A.L., Knopman D.S., Kaufer D.I., Grossman M., Onyike C., Graf-Radford N., Mendez M., Kerwin D., Lerner A., Wu C.K., Koestler M., Shapira J., Sullivan K., Klepac K., Lipowski K., Ullah J., Fields S., Kramer J.H., Merrilees J., Neuhaus J., Mesulam M.M., Miller B.L. Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2013, 12:149-156.
7. Cairns N.J., Bigio E.H., Mackenzie I.R., Neumann M., Lee V.M., Hatanpaa K.J., White C.L., Schneider J.A., Grinberg L.T., Halliday G., Duyckaerts C., Lowe J.S., Holm I.E., Tolnay M., Okamoto K., Yokoo H., Murayama S., Woulfe J., Munoz D.G., Dickson D.W., Ince P.G., Trojanowski J.Q., Mann D.M. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 2007, 114:5-22.
8. Chare L., Hodges J.R., Leyton C.E., McGinley C., Tan R.H., Kril J.J., Halliday G.M. New criteria for frontotemporal dementia syndromes: Clinical and pathological diagnostic implications. J. Neurol. Neurosurg. Psychiatry 2014, http://dx.doi.org/10.1136/jnnp-2013-306948.
9. Cruts M., Gijselinck I., van der Zee J., Engelborghs S., Wils H., Pirici D., Rademakers R., Vandenberghe R., Dermaut B., Martin J.J., van Duijn C., Peeters K., Sciot R., Santens P., De Pooter T., Mattheijssens M., Van den Broeck M., Cuijt I., Vennekens K., De Deyn P.P., Kumar-Singh S., Van Broeckhoven C. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006, 442:920-924.
10. Cuyvers E., Bettens K., Philtjens S., Van Langenhove T., Gijselinck I., van der Zee J., Engelborghs S., Vandenbulcke M., Van Dongen J., Geerts N., Maes G., Mattheijssens M., Peeters K., Cras P., Vandenberghe R., De Deyn P.P., Van Broeckhoven C., Cruts M., Sleegers K. Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia. Neurobiol. Aging 2014, 35:726.e11-726.e19.
11. DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., Kouri N., Wojtas A., Sengdy P., Hsiung G.Y., Karydas A., Seeley W.W., Josephs K.A., Coppola G., Geschwind D.H., Wszolek Z.K., Feldman H., Knopman D.S., Petersen R.C., Miller B.L., Dickson D.W., Boylan K.B., Graff-Radford N.R., Rademakers R. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72:245-256.
12. Dobson-Stone C., Hallupp M., Loy C.T., Thompson E.M., Haan E., Sue C.M., Panegyres P.K., Razquin C., Seijo-Martinez M., Rene R., Gascon J., Campdelacreu J., Schmoll B., Volk A.E., Brooks W.S., Schofield P.R., Pastor P., Kwok J.B. C9ORF72 repeat expansion in Australian and Spanish frontotemporal dementia patients. PLoS One 2013, 8:e56899.
13. Gorno-Tempini M.L., Murray R.C., Rankin K.P., Weiner M.W., Miller B.L. Clinical, cognitive and anatomical evolution from nonfluent progressive aphasia to corticobasal syndrome: a case report. Neurocase 2004, 10:426-436.
14. Gorno-Tempini M.L., Hillis A.E., Weintraub S., Kertesz A., Mendez M., Cappa S.F., Ogar J.M., Rohrer J.D., Black S., Boeve B.F., Manes F., Dronkers N.F., Vandenberghe R., Rascovsky K., Patterson K., Miller B.L., Knopman D.S., Hodges J.R., Mesulam M.M., Grossman M. Classification of primary progressive aphasia and its variants. Neurology 2011, 76:1006-1014.
15. Guerreiro R., Wojtas A., Bras J., Carrasquillo M., Rogaeva E., Majounie E., Cruchaga C., Sassi C., Kauwe J.S., Younkin S., Hazrati L., Collinge J., Pocock J., Lashley T., Williams J., Lambert J.C., Amouyel P., Goate A., Rademakers R., Morgan K., Powell J., St George-Hyslop P., Singleton A., Hardy J. TREM2 variants in Alzheimer's disease. New Engl. J. Med. 2013, 368:117-127.
16. Guerreiro R.J., Lohmann E., Bras J.M., Gibbs J.R., Rohrer J.D., Gurunlian N., Dursun B., Bilgic B., Hanagasi H., Gurvit H., Emre M., Singleton A., Hardy J. Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement. JAMA Neurol. 2013, 70:78-84.
17. Hernandez I., Mauleon A., Rosense-Roca M., Alegret M., Vinyes G., Espinosa A., Sotolongo-Grau O., Becker J.T., Valero S., Tarraga L., Lopez O.L., Ruiz A., Boada M. Identification of misdiagnosed fronto-temporal dementia using APOE genotype and phenotype-genotype correlation analyses. Curr. Alzheimer. Res. 2014, 11:182-191.
18. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R.C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J.M., Nowotny P., Che L.K., Norton J., Morris J.C., Reed L.A., Trojanowski J., Basun H., Lannfelt L., Neystat M., Fahn S., Dark F., Tannenberg T., Dodd P.R., Hayward N., Kwok J.B., Schofield P.R., Andreadis A., Snowden J., Craufurd D., Neary D., Owen F., Oostra B.A., Hardy J., Goate A., van Swieten J., Mann D., Lynch T., Heutink P. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998, 393:702-705.
19. Jessen F., Wiese B., Bickel H., Eifflander-Gorfer S., Fuchs A., Kaduszkiewicz H., Kohler M., Luck T., Mosch E., Pentzek M., Riedel-Heller S.G., Wagner M., Weyerer S., Maier W., van den Bussche H. Prediction of dementia in primary care patients. PLoS One 2011, 6:e16852.
20. Kornhuber J., Schmidtke K., Frolich L., Perneczky R., Wolf S., Hampel H., Jessen F., Heuser I., Peters O., Weih M., Jahn H., Luckhaus C., Hull M., Gertz H.J., Schroder J., Pantel J., Rienhoff O., Seuchter S.A., Ruther E., Henn F., Maier W., Wiltfang J. Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence Network. Dement. Geriatr. Cogn. Disord. 2009, 27:404-417.
21. Lattante S., Le Ber I., Camuzat A., Dayan S., Godard C., Van Bortel I., De Septenville A., Ciura S., Brice A., Kabashi E. TREM2 mutations are rare in a French cohort of patients with frontotemporal dementia. Neurobiol. Aging 2013, 34:2443.e1-2443.e2.
22. Luck T., Riedel-Heller S.G., Kaduszkiewicz H., Bickel H., Jessen F., Pentzek M., Wiese B., Koelsch H., van den Bussche H., Abholz H.H., Moesch E., Gorfer S., Angermeyer M.C., Maier W., Weyerer S. Mild cognitive impairment in general practice: age-specific prevalence and correlate results from the German study on ageing, cognition and dementia in primary care patients (AgeCoDe). Dement. Geriatr. Cogn. Disord. 2007, 24:307-316.
23. McKhann G.M., Albert M.S., Grossman M., Miller B., Dickson D., Trojanowski J.Q. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch. Neurol. 2001, 58:1803-1809.
24. Neary D., Snowden J.S., Gustafson L., Passant U., Stuss D., Black S., Freedman M., Kertesz A., Robert P.H., Albert M., Boone K., Miller B.L., Cummings J., Benson D.F. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998, 51:1546-1554.
25. Paloneva J., Manninen T., Christman G., Hovanes K., Mandelin J., Adolfsson R., Bianchin M., Bird T., Miranda R., Salmaggi A., Tranebjaerg L., Konttinen Y., Peltonen L. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am. J. Hum. Genet. 2002, 71:656-662.
26. Pastor P. Comment: double mutants of frontotemporal dementia genes-simple co-occurrence?. Neurology 2013, 81:1338.
27. Pastor P., Pastor E., Carnero C., Vela R., Garcia T., Amer G., Tolosa E., Oliva R. Familial atypical progressive supranuclear palsy associated with homozygosity for the delN296 mutation in the tau gene. Ann. Neurol. 2001, 49:263-267.
28. Rascovsky K., Hodges J.R., Knopman D., Mendez M.F., Kramer J.H., Neuhaus J., van Swieten J.C., Seelaar H., Dopper E.G., Onyike C.U., Hillis A.E., Josephs K.A., Boeve B.F., Kertesz A., Seeley W.W., Rankin K.P., Johnson J.K., Gorno-Tempini M.L., Rosen H., Prioleau-Latham C.E., Lee A., Kipps C.M., Lillo P., Piguet O., Rohrer J.D., Rossor M.N., Warren J.D., Fox N.C., Galasko D., Salmon D.P., Black S.E., Mesulam M., Weintraub S., Dickerson B.C., Diehl-Schmid J., Pasquier F., Deramecourt V., Lebert F., Pijnenburg Y., Chow T.W., Manes F., Grafman J., Cappa S.F., Freedman M., Grossman M., Miller B.L. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011, 134(Pt 9):2456-2477.
29. Renton A.E., Majounie E., Waite A., Simon-Sanchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., Kalimo H., Paetau A., Abramzon Y., Remes A.M., Kaganovich A., Scholz S.W., Duckworth J., Ding J., Harmer D.W., Hernandez D.G., Johnson J.O., Mok K., Ryten M., Trabzuni D., Guerreiro R.J., Orrell R.W., Neal J., Murray A., Pearson J., Jansen I.E., Sondervan D., Seelaar H., Blake D., Young K., Halliwell N., Callister J.B., Toulson G., Richardson A., Gerhard A., Snowden J., Mann D., Neary D., Nalls M.A., Peuralinna T., Jansson L., Isoviita V.M., Kaivorinne A.L., Holtta-Vuori M., Ikonen E., Sulkava R., Benatar M., Wuu J., Chio A., Restagno G., Borghero G., Sabatelli M., Heckerman D., Rogaeva E., Zinman L., Rothstein J.D., Sendtner M., Drepper C., Eichler E.E., Alkan C., Abdullaev Z., Pack S.D., Dutra A., Pak E., Hardy J., Singleton A., Williams N.M., Heutink P., Pickering-Brown S., Morris H.R., Tienari P.J., Traynor B.J. Ahexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011, 72:257-268.
30. Ruiz A., Dols-Icardo O., Bullido M.J., Pastor P., Rodriguez-Rodriguez E., Lopez de Munain A., de Pancorbo M.M., Perez-Tur J., Alvarez V., Antonell A., Lopez-Arrieta J., Hernandez I., Tarraga L., Boada M., Lleo A., Blesa R., Frank-Garcia A., Sastre I., Razquin C., Ortega-Cubero S., Lorenzo E., Sanchez-Juan P., Combarros O., Moreno F., Gorostidi A., Elcoroaristizabal X., Baquero M., Coto E., Sanchez-Valle R., Clarimon J. Assessing the role of the TREM2p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia. Neurobiol. Aging 2014, 35:444.e1-444.e2.
31. van Blitterswijk M., Baker M.C., DeJesus-Hernandez M., Ghidoni R., Benussi L., Finger E., Hsiung G.Y., Kelley B.J., Murray M.E., Rutherford N.J., Brown P.E., Ravenscroft T., Mullen B., Ash P.E., Bieniek K.F., Hatanpaa K.J., Karydas A., Wood E.M., Coppola G., Bigio E.H., Lippa C., Strong M.J., Beach T.G., Knopman D.S., Huey E.D., Mesulam M., Bird T., White C.L., Kertesz A., Geschwind D.H., Van Deerlin V.M., Petersen R.C., Binetti G., Miller B.L., Petrucelli L., Wszolek Z.K., Boylan K.B., Graff-Radford N.R., Mackenzie I.R., Boeve B.F., Dickson D.W., Rademakers R. C9ORF72 repeat expansions in cases with previously identified pathogenic mutations. Neurology 2013, 81:1332-1341.
32. Warren J.D., Fletcher P.D., Golden H.L. The paradox of syndromic diversity in Alzheimer disease. Nat. Rev. Neurol. 2012, 8:451-464.